# Eli Lilly and Company (LLY) — Q3-2015 Earnings Results

**Report date:** 2015-10-22 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q3-2015

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down 0.04%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.89 | N/A | +17.72% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's direction. They emphasized their commitment to growth and innovation.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing efforts to innovate and improve product offerings.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted slightly down by 0.04%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue figures and future guidance could lead to uncertainty among investors moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q3-2015_